AuthorsHowell, Sacha J
AffiliationThe University of Manchester, Institute of Cancer Studies, Manchester, UK.
MetadataShow full item record
AbstractRecent advances in the genomic analysis of breast cancers show promise in better defining endocrine sensitive subtypes. In addition, several key trials have recently reported results that better define the optimal sequence of endocrine agents and approaches to overcome endocrine resistance.
CitationAdvances in the treatment of luminal breast cancer. 2013, 25 (1):49-54 Curr Opin Obstet Gynecol
JournalCurrent Opinion in Obstetrics & Gynecology